Login   |  Users Online: 364 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
RESEARCH ARTICLE
Year : 2009  |  Volume : 30  |  Issue : 2  |  Page : 164-170

A clinical study on the management of Amavata (Rheumatoid arthritis) with Simhanada guggulu and Alambushadi churna tablet


1 Ph.D. (Ayu.), Dept. of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
2 Professor & H.O.D., Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India

Correspondence Address:
Saroj Kumar Debnath
Ph.D. (Ayu.), Dept. of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

In this clinical study, 90 patients of Amavata (Rheumatoid arthritis) were registered from the O.P.D. & I.P.D., Deptt. of the Kayachikitsa, I.P.G.T. & R.A., G.A.U., Jamnagar. In Group-A, 40 patients completed the treatment out of 44 patients and 4 patients left the treatment before completion of the course and the treatment schedule was :- Alambushadi churna 4 tablets orally thrice daily with warm milk for 45 days (Each tablet containing 500mg Alambushadi churna) along with 1gm Simhanada guggulu orally thrice daily with warm water for 45 days and Shatapushpadi lepa applied locally over affected joints with warm water for 45 days. In Group-B, 40 patients completed the treatment out of 46 patients and 4 patients left the treatment before completion of the course. The treatment schedule was : Simhanada guggulu & Shatapushpadi lepa both given in same dose & duration as in Group-A. In Group-A maximum patients i.e. 65 % showed major improvement, while in Group-B maximum patients i.e. 50 % showed minor improvement. No side effects of the research drugs were observed during the clinical trial. Group-A therapy is more effective than Group-B therapy in this clinical study.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed859    
    Printed52    
    Emailed1    
    PDF Downloaded375    
    Comments [Add]    

Recommend this journal